Daratumumab in transfusion‐dependent patients with low or intermediate‐1 risk myelodysplastic syndromes.

Autor: Garcia‐Manero, Guillermo, Diez‐Campelo, Maria, Vellenga, Edo, Jacoby, Meagan A., Merchan, Brayan, Breems, Dimitri, Cortelezzi, Agostino, Doronin, Vadim, Gomez, Valle, Beckers, Marielle, Della Porta, Matteo Giovanni, Varsos, Helen, Xiu, Liang, DeAngelis, Nikki, Nnane, Ivo, Rose, Esther, Eygen, Koen
Zdroj: American Journal of Hematology; Apr2021, Vol. 96 Issue 4, pE111-E114, 4p
Databáze: Complementary Index
Externí odkaz: